The role of Wnt pathway antagonists in early-stage lung adenocarcinoma
- 15 November 2021
- journal article
- research article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 49 (1) , 9-17
Abstract
Purpose We aimed to examine the expression levels of the genes encoding adenomatous polyposis coli (APC) 1, APC-2, Dickkopf related protein (DKK)-1, DKK-3, secreted frizzled-related protein (SFRP)-2, SFRP-4, and SFRP-5, which play roles in the Wnt signaling pathway, in lung adenocarcinoma and adjacent normal lung tissues and to evaluate their relationships with clinicopathologic factors. Materials and methods The expression levels of genes in formalin-fixed paraffin-embedded samples of tumor tissue and adjacent intact lung tissue from 57 patients who underwent surgery for lung adenocarcinoma between 2011 and 2018 were determined by real-time PCR analysis. Results The expression levels of the DKK-1 in tumor tissue, especially in stage I–II tumor tissue, were significantly suppressed compared to those in normal tissue (p < 0.025). Whereas DKK-1 expression was suppressed in the tumor tissue of patients with early-stage lung adenocarcinoma, expression of the SFRP-5 in these patients was significantly higher in tumor tissue than in normal tissue (p < 0.039). Conclusion In our study, opposing regulation was found between the SFRP-5 and DKK-1, which are known to be extracellular antagonists of the Wnt signaling pathway. The SFRP-5 was found to have an oncogenic role in adenocarcinoma development. Studies of the opposing regulation between these genes in early-stage lung adenocarcinoma may shed light on the mechanisms associated with the development of carcinogenesis. The relationships or interactions of these genes may serve as potential therapeutic targets.Keywords
Funding Information
- MUĞLA SITKI KOÇMAN UNIVERSITY (. This work was supported by Mugla Sıtkı Koçman University with project number 19/087/07/3/4)
This publication has 40 references indexed in Scilit:
- DNA Methylation status of Wnt antagonist SFRP5 can predict the response to the EGFR-tyrosine kinase inhibitor therapy in non-small cell lung cancerJournal of Experimental & Clinical Cancer Research, 2012
- Dickkopf-1 autoantibody is a novel serological biomarker for non-small cell lung cancerBiomarkers, 2009
- Towards an integrated view of Wnt signaling in developmentDevelopment, 2009
- Clinical Significance and Prognostic Value of Serum Dickkopf-1 Concentrations in Patients with Lung CancerClinical Chemistry, 2009
- Analyzing real-time PCR data by the comparative CT methodNature Protocols, 2008
- The single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction: twenty-something years onNature Protocols, 2006
- Invasion and Metastasis in Colorectal Cancer: Epithelial-Mesenchymal Transition, Mesenchymal-Epithelial Transition, Stem Cells and β-CateninCells Tissues Organs, 2005
- A Second CanonDevelopmental Cell, 2003
- KEGG: Kyoto Encyclopedia of Genes and GenomesNucleic Acids Research, 2000
- Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cellNature Medicine, 1997